Hidde L. Ploegh

Hidde L. Ploegh

Auto-generated profile, based on publicly available information

Hidde L. Ploegh

Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 1997 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
MBMatthew Bogyo
Matthew Bogyo
JMJohn S. McMaster
John S. McMaster
MGMaria Gaczynska
Maria Gaczynska
DTDomenico Tortorella
Domenico Tortorella
AGAlfred L. Goldberg
Alfred L. Goldberg
HPHidde Ploegh
Hidde Ploegh
The proteasome is a multicatalytic protease complex that plays a key role in diverse cellular functions. The peptide vinyl sulfone, carboxybenzyl-leucyl-leucyl-leucine vinyl sulfone (Z-L3VS) covalently inhibits the trypsin-like, chymotrypsin-like and, unlike lactacystin, also the peptidylglutamyl peptidase activity in isolated proteasomes, and blocks their function in living cells. Although described as a class of mechanism-based inhibitors for cysteine proteases, the peptide vinyl sulfone Z-L3VS and a125I-labeled nitrophenol derivative (125I-NIP-L3VS) covalently modify the active site threonine of the catalytic β subunits of the proteasome. Modification of Thermoplasma proteasomes demonstrates the requirement for a hydroxyl amino acid (threonine, serine) as nucleophile at the β subunit’s NH2terminus.125I-NIP-L3VS covalently modifies the HslV subunit of theEscherichia coliprotease complex HslV/HslU, a reaction that requires ATP, and supports a catalytic mechanism shared with that of the eukaryotic proteasome.

15 November 1999 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
CDChristoph Driessen
Christoph Driessen
RBRebecca A.R. Bryant
Rebecca A.R. Bryant
ALAna-Maria Lennon-Duménil
Ana-Maria Lennon-Duménil
JVJosé A. Villadangos
José A. Villadangos
PBPaula Wolf Bryant
Paula Wolf Bryant
HPHidde L. Ploegh
Hidde L. Ploegh
Before a class II molecule can be loaded with antigenic material and reach the surface to engage CD4+ T cells, its chaperone, the class II-associated invariant chain (Ii), is degraded in a stepwise fashion by proteases in endocytic compartments. We have dissected the role of cathepsin S (CatS) in the trafficking and maturation of class II molecules by combining the use of dendritic cells (DC) from CatS−/− mice with a new active site–directed probe for direct visualization of active CatS. Our data demonstrate that CatS is active along the entire endocytic route, and that cleavage of the lysosomal sorting signal of Ii by CatS can occur there in mature DC. Genetic disruption of CatS dramatically reduces the flow of class II molecules to the cell surface. In CatS−/− DC, the bulk of major histocompatibility complex (MHC) class II molecules is retained in late endocytic compartments, although paradoxically, surface expression of class II is largely unaffected. The greatly diminished but continuous flow of class II molecules to the cell surface, in conjunction with their long half-life, can account for the latter observation. We conclude that in DC, CatS is a major determinant in the regulation of intracellular trafficking of MHC class II molecules.

18 August 1997 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JVJosé A. Villadangos
José A. Villadangos
RRRichard J. Riese
Richard J. Riese
CPChristoph Peters
Christoph Peters
HCHarold A. Chapman
Harold A. Chapman
HPHidde L. Ploegh
Hidde L. Ploegh
Antigen-presenting cells (APC) degrade endocytosed antigens into peptides that are bound and presented to T cells by major histocompatibility complex (MHC) class II molecules. Class II molecules are delivered to endocytic compartments by the class II accessory molecule invariant chain (Ii), which itself must be eliminated to allow peptide binding. The cellular location of Ii degradation, as well as the enzymology of this event, are important in determining the sets of antigenic peptides that will bind to class II molecules. Here, we show that the cysteine protease cathepsin S acts in a concerted fashion with other cysteine and noncysteine proteases to degrade mouse Ii in a stepwise fashion. Inactivation of cysteine proteases results in incomplete degradation of Ii, but the extent to which peptide loading is blocked by such treatment varies widely among MHC class II allelic products. These observations suggest that, first, class II molecules associated with larger Ii remnants can be converted efficiently to class II–peptide complexes and, second, that most class II–associated peptides can still be generated in cells treated with inhibitors of cysteine proteases. Surprisingly, maturation of MHC class II in mice deficient in cathepsin D is unaffected, showing that this major aspartyl protease is not involved in degradation of Ii or in generation of the bulk of antigenic peptides.

4 August 1997 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JHJohannes B. Huppa
Johannes B. Huppa
HPHidde L. Ploegh
Hidde L. Ploegh
The T cell receptor for antigen (TCR) is a multisubunit complex that consists of at least seven polypeptides: the clonotypic, disulfide-linked α/β heterodimer that is noncovalently associated with the invariant polypeptides of the CD3 complex (CD3-γ, -δ, -ε) and ζ, a disulfide-linked homodimer. We achieved the complete assembly of the human TCR in an in vitro transcription/translation system supplemented with dog pancreas microsomes by simultaneous translation of the messenger RNAs encoding the TCR-α, -β and CD3-γ, -δ, -ε, and -ζ subunits. CD3-ε, one of the subunits that initiates the assembly of the TCR in living cells, forms misfolded, disulfide-linked homooligomers when translated alone. However, co-translation of one of its first binding partners in the course of assembly, CD3-γ or -δ, led to the expression of mainly monomeric and correctly folded ε subunits, the only form we could detect as part of a properly assembled TCR complex. In the absence of these subunits, the ER-resident chaperone calnexin interacted with oligomeric, i.e. misfolded, structures of CD3-ε in a glycan-independent manner. A glycan-dependent interaction between CD3-ε and calnexin was mediated by CD3-γ and concerned only monomeric CD3-ε complexed with CD3-γ, but was dispensable for proper folding of CD3-ε. We suggest that in addition to its signaling function, CD3-ε serves as a monitor for proper subunit assembly of the TCR.

1 March 1997 in Molecular Medicine Today
Verified
Journal Article
Closed access
PDF file
EWEmmanuel J.H.J. Wiertz
Emmanuel J.H.J. Wiertz
SMSiddhartha Mukherjee
Siddhartha Mukherjee
HPHidde L. Ploegh
Hidde L. Ploegh

1 June 1997 in Immunology Today
Verified
Journal Article
Closed access
HPHidde L. Ploegh
Hidde L. Ploegh